|
|
News Breaks | | | | January 8, 2013 | | 05:21 EDT |  | STSI | Star Scientific reports positive initial results of ASAP Human Thyroid Study
Star Scientific announced the preliminary results of the company's Anatabloc Supplementation Autoimmune Prevention, or ASAP, Human Thyroid Study that analyzes the impact of anatabine dietary supplementation on thyroid health. The study is a three-month, five-visit, double-blind, placebo-controlled study of the impact of anatabine dietary supplementation in humans with autoimmune disease of the thyroid. The study was conducted at nine sites and builds upon previous epidemiological and animal experimental studies. Initial results for all study subjects suggest that dietary supplementation with anatabine ameliorates the immune system's targeting of the thyroid gland in autoimmune thyroiditis. One-hundred forty-eight subjects completed the study, of which one-hundred forty six complied with all treatment, visits and required tests. The preliminary examination of the primary outcomes shows a clear and statistically significant difference in the treated group as compared to the placebo group by the end of the trial, with declines in anti-thyroglobulin antibody levels. Anatabine subjects also tended toward a reduction in thyroid gland vascularity on ultrasound relative to placebo. | |
|
News For STSI From The Last 14 Days Check below for free stories on STSI the last two weeks. |
|
|
| There are no results for STSI |
|
|
|
|
|
|
